Apyx Medical (NASDAQ:APYX) Trading 0.4% Higher - Should You Buy?

Apyx Medical Corporation (NASDAQ:APYX - Get Free Report)'s stock price was up 0.4% during mid-day trading on Tuesday . The company traded as high as $2.33 and last traded at $2.25. Approximately 41,910 shares traded hands during trading, a decline of 51% from the average daily volume of 85,852 shares. The stock had previously closed at $2.24.

Apyx Medical Stock Up 7.2%

The business has a 50-day moving average of $1.95 and a 200-day moving average of $1.49. The company has a debt-to-equity ratio of 3.21, a quick ratio of 4.64 and a current ratio of 5.45. The stock has a market capitalization of $95.99 million, a price-to-earnings ratio of -4.62 and a beta of 1.31.

Apyx Medical (NASDAQ:APYX - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported ($0.10) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.13) by $0.03. The firm had revenue of $9.43 million during the quarter, compared to the consensus estimate of $9.39 million. Apyx Medical had a negative return on equity of 156.85% and a negative net margin of 42.37%. On average, sell-side analysts expect that Apyx Medical Corporation will post -0.68 EPS for the current year.

Hedge Funds Weigh In On Apyx Medical

Several institutional investors have recently bought and sold shares of APYX. Nantahala Capital Management LLC acquired a new position in Apyx Medical in the 4th quarter valued at about $5,008,000. Silverberg Bernstein Capital Management LLC grew its position in shares of Apyx Medical by 38.7% during the second quarter. Silverberg Bernstein Capital Management LLC now owns 896,736 shares of the company's stock worth $2,018,000 after buying an additional 250,167 shares in the last quarter. Raymond James Financial Inc. acquired a new position in shares of Apyx Medical during the fourth quarter worth about $134,000. Kingsview Wealth Management LLC grew its position in shares of Apyx Medical by 29.5% during the first quarter. Kingsview Wealth Management LLC now owns 175,095 shares of the company's stock worth $240,000 after buying an additional 39,850 shares in the last quarter. Finally, Citadel Advisors LLC grew its position in shares of Apyx Medical by 130.6% during the fourth quarter. Citadel Advisors LLC now owns 66,355 shares of the company's stock worth $105,000 after buying an additional 37,582 shares in the last quarter. 55.33% of the stock is owned by institutional investors and hedge funds.

Apyx Medical Company Profile

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.